Enzaplatovir

• CAT Number: I006680
• CAS Number: 1323077-89-9
• Molecular Formula: C20H19N5O3
• Molecular Weight: 377.4
• Purity: ≥95%
• Synonyms: Enzaplatovir;BTA-585; BTA585; BTA 585; BTA-C585; BTAC585; BTA C585;(R)-1-(3-methylisoxazole-4-carbonyl)-10a-(6-methylpyridin-3-yl)-2,3,10,10a-tetrahydro-1H,5H-imidazo[1,2-a]pyrrolo[1,2-d]pyrazin-5-one
• Target: Viral Fusion Protein Inhibitor
• Solubility: Soluble in DMSO
• Storage: Store at -20°C
• IUPAC Name: (3R)-4-(3-methyl-1,2-oxazole-4-carbonyl)-3-(6-methylpyridin-3-yl)-1,4,7-triazatricyclo[7.3.0.03,7]dodeca-9,11-dien-8-one
• InChI: InChI=1S/C20H19N5O3/c1-13-5-6-15(10-21-13)20-12-23-7-3-4-17(23)19(27)25(20)9-8-24(20)18(26)16-11-28-22-14(16)2/h3-7,10-11H,8-9,12H2,1-2H3/t20-/m0/s1
• InChIKey: KUDXTBCRESIJFH-FQEVSTJZSA-N
• SMILES: CC1=NC=C(C=C1)C23CN4C=CC=C4C(=O)N2CCN3C(=O)C5=CON=C5C

Enzaplatovir（Cat No.:I006680） is a potent inhibitor of the Respiratory Syncytial Virus (RSV), a leading cause of respiratory illness in young children and the elderly. It acts by inhibiting the viral fusion protein, preventing the virus from entering host cells and replicating. Enzaplatovir has shown efficacy in preclinical studies against various RSV strains and has the potential to be used as a treatment for RSV infections.